154 related articles for article (PubMed ID: 30327235)
1. Optimized upstream and downstream process conditions for the improved production of recombinant human asparaginase (rhASP) from Escherichia coli and its characterization.
Kante RK; Vemula S; Somavarapu S; Mallu MR; Boje Gowd BH; Ronda SR
Biologicals; 2018 Nov; 56():45-53. PubMed ID: 30327235
[TBL] [Abstract][Full Text] [Related]
2. Improved Production and Characterization of Recombinant Human Granulocyte Colony Stimulating Factor from E. coli under Optimized Downstream Processes.
Vemula S; Thunuguntla R; Dedaniya A; Kokkiligadda S; Palle C; Ronda SR
Protein Expr Purif; 2015 Apr; 108():62-72. PubMed ID: 25659501
[TBL] [Abstract][Full Text] [Related]
3. Efficient and easily scalable protein folding strong anion exchange chromatography for renaturation and simultaneous purification of recombinant human asparaginase from E. coli.
Kante RK; Vemula S; Mallu MR; Ronda SR
Biotechnol Prog; 2018 Jul; 34(4):1036-1044. PubMed ID: 29708643
[TBL] [Abstract][Full Text] [Related]
4. Recombinant production of biologically active giant grouper (Epinephelus lanceolatus) growth hormone from inclusion bodies of Escherichia coli by fed-batch culture.
Chung WJ; Huang CL; Gong HY; Ou TY; Hsu JL; Hu SY
Protein Expr Purif; 2015 Jun; 110():79-88. PubMed ID: 25703054
[TBL] [Abstract][Full Text] [Related]
5. High throughput purification of recombinant human growth hormone using radial flow chromatography.
Singh SM; Sharma A; Panda AK
Protein Expr Purif; 2009 Nov; 68(1):54-9. PubMed ID: 19500673
[TBL] [Abstract][Full Text] [Related]
6. Recovery of bioactive protein from bacterial inclusion bodies using trifluoroethanol as solubilization agent.
Upadhyay V; Singh A; Jha D; Singh A; Panda AK
Microb Cell Fact; 2016 Jun; 15():100. PubMed ID: 27277580
[TBL] [Abstract][Full Text] [Related]
7. Purification of recombinant ovalbumin from inclusion bodies of Escherichia coli.
Upadhyay V; Singh A; Panda AK
Protein Expr Purif; 2016 Jan; 117():52-8. PubMed ID: 26390939
[TBL] [Abstract][Full Text] [Related]
8. Bioprocessing of therapeutic proteins from the inclusion bodies of Escherichia coli.
Panda AK
Adv Biochem Eng Biotechnol; 2003; 85():43-93. PubMed ID: 12930093
[TBL] [Abstract][Full Text] [Related]
9. Optimization of human granulocyte macrophage-colony stimulating factor (hGM-CSF) expression using asparaginase and xylanase gene's signal sequences in Escherichia coli.
Khasa YP; Khushoo A; Tapryal S; Mukherjee KJ
Appl Biochem Biotechnol; 2011 Sep; 165(2):523-37. PubMed ID: 21562804
[TBL] [Abstract][Full Text] [Related]
10. Expression and purification of recombinant human granulocyte colony-stimulating factor in fed-batch culture of Escherichia coli.
Kim CK; Choi JH; Lee SB; Lee SM; Oh JW
Appl Biochem Biotechnol; 2014 Mar; 172(5):2425-35. PubMed ID: 24390866
[TBL] [Abstract][Full Text] [Related]
11. Refolding and purification of recombinant human (Pro)renin receptor from Escherichia coli by ion exchange chromatography.
Wang F; Guo J; Bai Q; Wang L
Biotechnol Prog; 2014; 30(4):864-71. PubMed ID: 24723509
[TBL] [Abstract][Full Text] [Related]
12. Molecular expression of l-asparaginase gene from Nocardiopsis alba NIOT-VKMA08 in Escherichia coli: A prospective recombinant enzyme for leukaemia chemotherapy.
Meena B; Anburajan L; Vinithkumar NV; Shridhar D; Raghavan RV; Dharani G; Kirubagaran R
Gene; 2016 Sep; 590(2):220-6. PubMed ID: 27155523
[TBL] [Abstract][Full Text] [Related]
13. Continuous refolding of L-asparaginase inclusion bodies using periodic counter-current chromatography.
Rajendran V; Pushpavanam S; Jayaraman G
J Chromatogr A; 2022 Jan; 1662():462746. PubMed ID: 34936904
[TBL] [Abstract][Full Text] [Related]
14. One-step purification and kinetic properties of the recombinant L-asparaginase from Erwinia carotovora.
Krasotkina J; Borisova AA; Gervaziev YV; Sokolov NN
Biotechnol Appl Biochem; 2004 Apr; 39(Pt 2):215-21. PubMed ID: 15032742
[TBL] [Abstract][Full Text] [Related]
15. Refolding and purification of recombinant human VEGF-121 expressed as inclusion bodies in Escherichia coli.
Hu ZM; Ma L; Zhou MQ; Gao JM; Wang XN
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1083-6. PubMed ID: 16939889
[TBL] [Abstract][Full Text] [Related]
16. High-yield expression of human vascular endothelial growth factor VEGF(165) in Escherichia coli and purification for therapeutic applications.
Pizarro SA; Gunson J; Field MJ; Dinges R; Khoo S; Dalal M; Lee M; Kaleas KA; Moiseff K; Garnick S; Reilly DE; Laird MW; Schmelzer CH
Protein Expr Purif; 2010 Aug; 72(2):184-93. PubMed ID: 20302942
[TBL] [Abstract][Full Text] [Related]
17. A novel method to recover inclusion body protein from recombinant E. coli fed-batch processes based on phage ΦX174-derived lysis protein E.
Ehgartner D; Sagmeister P; Langemann T; Meitz A; Lubitz W; Herwig C
Appl Microbiol Biotechnol; 2017 Jul; 101(14):5603-5614. PubMed ID: 28429059
[TBL] [Abstract][Full Text] [Related]
18. Optimization of conditions for high-level expression and purification of human recombinant consensus interferon (rh-cIFN) and its characterization.
Ahmed N; Bashir H; Zafar AU; Khan MA; Tahir S; Khan F; Khan MI; Akram M; Husnain T
Biotechnol Appl Biochem; 2015; 62(5):699-708. PubMed ID: 25402716
[TBL] [Abstract][Full Text] [Related]
19. High pH solubilization and chromatography-based renaturation and purification of recombinant human granulocyte colony-stimulating factor from inclusion bodies.
Li M; Fan H; Liu J; Wang M; Wang L; Wang C
Appl Biochem Biotechnol; 2012 Mar; 166(5):1264-74. PubMed ID: 22212394
[TBL] [Abstract][Full Text] [Related]
20. Expression, purification, and bioactivity of human tumstatin from Escherichia coli.
Gu Q; Zhang T; Luo J; Wang F
Protein Expr Purif; 2006 Jun; 47(2):461-6. PubMed ID: 16503164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
